We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+48.85%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$634M
AUM Growth
+$33.5M
(+5.6%)
Cap. Flow
-$90.2M
Cap. Flow
% of AUM
-14.22%
Top 10 Holdings %
Top 10 Hldgs %
8.15%
Holding
413
New
130
Increased
19
Reduced
118
Closed
127
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LivePerson
LPSN
|
+$4.19M |
| 2 |
NVTR
Nuvectra Corporation Common Stock
NVTR
|
+$4.14M |
| 3 |
TBCH
Turtle Beach Corp
TBCH
|
+$4.13M |
| 4 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$4.07M |
| 5 |
Tactile Systems Technology
TCMD
|
+$4.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$6.81M |
| 2 |
CUTR
Cutera, Inc.
CUTR
|
+$4.92M |
| 3 |
Vericel Corp
VCEL
|
+$4.77M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$4.75M |
| 5 |
INST
Instructure, Inc.
INST
|
+$4.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.66% |
| 2 | Technology | 24.9% |
| 3 | Consumer Discretionary | 14.4% |
| 4 | Industrials | 10.81% |
| 5 | Financials | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Liquidity Services
LQDT
$1.22B
| – | – |
-87,374
| Closed | -$568K |
|
327
Monarch Casino & Resort
MCRI
$2.2B
| – | – |
-22,540
| Closed | -$953K |
|
328
MKS Inc
MKSI
$20.1B
| – | – |
-21,493
| Closed | -$2.49M |
|
329
Merit Medical Systems
MMSI
$5.08B
| – | – |
-59,891
| Closed | -$2.72M |
|
330
Modine Manufacturing
MOD
$10.7B
| – | – |
-43,485
| Closed | -$920K |
|
331
Neurocrine Biosciences
NBIX
$16.8B
| – | – |
-41,529
| Closed | -$3.44M |
|
332
Ingevity
NGVT
$2.51B
| – | – |
-34,140
| Closed | -$2.52M |
|
|
333
Nektar Therapeutics
NKTR
$2.39B
| – | – |
-4,270
| Closed | -$6.81M |
|
334
Nutanix
NTNX
$16B
| – | – |
-85,762
| Closed | -$4.21M |
|
335
Novavax
NVAX
$1.2B
| – | – |
-21,552
| Closed | -$905K |
|
336
New York Times
NYT
$12.1B
| – | – |
-117,334
| Closed | -$2.83M |
|
337
Okta
OKTA
$24.7B
| – | – |
-75,506
| Closed | -$3.01M |
|
338
Paycom
PAYC
$7.64B
| – | – |
-31,881
| Closed | -$3.42M |
|
339
Preferred Bank
PFBC
$1.24B
| – | – |
-62,550
| Closed | -$4.02M |
|
340
Pool Corp
POOL
$6.75B
| – | – |
-18,374
| Closed | -$2.69M |
|
|
PRO
341
DELISTED
PROS Holdings
PRO
| – | – |
-40,907
| Closed | -$1.35M |
|
|
P
342
Everpure Inc
P
$25.7B
| – | – |
-155,256
| Closed | -$3.1M |
|
343
QuinStreet
QNST
$890M
| – | – |
-105,599
| Closed | -$1.35M |
|
344
Riverview Bancorp
RVSB
$107M
| – | – |
-59,710
| Closed | -$558K |
|
|
SAGE
345
DELISTED
Sage Therapeutics
SAGE
| – | – |
-18,221
| Closed | -$2.94M |
|
346
Saia
SAIA
$9.27B
| – | – |
-29,681
| Closed | -$2.23M |
|
347
SolarEdge
SEDG
$2.51B
| – | – |
-15,684
| Closed | -$825K |
|
348
Superior Group of Companies
SGC
$185M
| – | – |
-25,404
| Closed | -$667K |
|
|
SGMO
349
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| – | – |
-219,415
| Closed | -$4.17M |
|
|
SHYF
350
DELISTED
The Shyft Group
SHYF
| – | – |
-49,395
| Closed | -$850K |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q2 2018 Portfolio in Review
As of Q2 2018, EAM Investors held 413 positions worth $634M, up 5.6% from $601M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
EAM Investors withdrew a net $90.2M in Q2 2018, closing 127 positions and reducing 118 holdings. Its most notable exit was Nektar Therapeutics, an estimated $6.81M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, EAM Investors opened a new position in LivePerson worth $4.69M.
- EAM Investors's largest Q2 2018 buy was LivePerson: 14,807 shares worth $4.69M.
- EAM Investors added most to Malibu Boats in Q2 2018, an estimated $3.06M increase.
- EAM Investors's biggest Q2 2018 reduction was Vericel Corp, cutting an estimated $4.77M.
- EAM Investors fully exited Nektar Therapeutics in Q2 2018, selling an estimated $6.81M.
- EAM Investors's ten largest holdings make up 8.1% of its $634M portfolio in Q2 2018.
- EAM Investors opened 130 new positions and closed 127 in Q2 2018.
- EAM Investors's portfolio value rose 5.6% quarter-over-quarter to $634M.
Based on EAM Investors's 13F filing for Q2 2018, filed 3 Aug 2018.